Get Real Stocks

BCAX · Bicara Therapeutics

Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Country
United States

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines a clinically validated epidermal growth factor receptor directed monoclonal antibody bound to human transforming growth factor beta for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.

24h Volume by Exchange

No Data Yet

Issuer
Price
$22.78
24h Volume
-
Depth (±1%)
-